000759997 000__ 04704cam\a2200469Ii\4500
000759997 001__ 759997
000759997 005__ 20230306141943.0
000759997 006__ m\\\\\o\\d\\\\\\\\
000759997 007__ cr\cn\nnnunnun
000759997 008__ 160811s2016\\\\sz\\\\\\o\\\\\001\0\eng\d
000759997 020__ $$a9783319423609$$q(electronic book)
000759997 020__ $$a3319423606$$q(electronic book)
000759997 020__ $$z9783319423593
000759997 035__ $$aSP(OCoLC)ocn956505404
000759997 035__ $$aSP(OCoLC)956505404
000759997 040__ $$aN$T$$beng$$erda$$epn$$cN$T$$dGW5XE$$dIDEBK$$dOCLCQ$$dOCLCO$$dEBLCP$$dOCLCF
000759997 049__ $$aISEA
000759997 050_4 $$aQR100.8.B55
000759997 08204 $$a579/.17$$223
000759997 24500 $$aFungal biofilms and related infections$$h[electronic resource] :$$badvances in microbiology, infectious diseases and public health.$$nVolume 3 /$$cChristine Imbert, editor.
000759997 264_1 $$aSwitzerland :$$bSpringer,$$c2016.
000759997 300__ $$a1 online resource (v, 130 pages).
000759997 336__ $$atext$$btxt$$2rdacontent
000759997 337__ $$acomputer$$bc$$2rdamedia
000759997 338__ $$aonline resource$$bcr$$2rdacarrier
000759997 4901_ $$aAdvances in experimental medicine and biology, Advances in microbiology, infectious diseases and public health,$$x0065-2598 ;$$vvolume 931
000759997 500__ $$aIncludes index.
000759997 5050_ $$aAspergillus Biofilms in Human Disease; 1 Introduction; 2 Where May Aspergillus Biofilms Be Important?; 2.1 Upper Airways; 2.2 Lower Airways; 3 Wounds; 4 Medical Devices; 5 Antifungal Treatments; 6 Efflux Pumps; 7 Extracellular Matrix; 8 Previous Therapy; 9 Other Approaches; 10 Concluding Remarks; References; Candida albicans in Multispecies Oral Communities; A Keystone Commensal?; 1 Introduction; 1.1 The Oral Cavity; 1.2 Oral Ecology; 1.3 Oral Fungi Focussed on Disease; 1.4 Oral Fungi in Health; 2 Type of Bacterium-Fungus Interactions Related to Health; 2.1 Physical Interactions
000759997 5058_ $$aBox 1: How oral bacteria impact healthy physiology2.2 Chemical Interactions; 2.3 Metabolic Interactions; 3 Keystone Organisms ́Theory; 3.1 Keystone Pathogens in Oral Diseases; 4 Conclusion; References; The Extracellular Matrix of Fungal Biofilms; 1 Introduction; 2 Matrix of Bacterial Biofilms; 3 Fungal Matrix; 3.1 Tools for Studying the Matrix; 3.2 Saccharomyces cerevisiae; 3.3 Aspergillus fumigatus; 3.4 Cryptococcus neoformans; 3.5 Candida; 3.6 Role of Candida Matrix in Drug Resistance; 4 Conclusions; References; Fungal Biofilms: Update on Resistance; 1 Introduction
000759997 5058_ $$a2 The Extracellular Matrix2.1 Matrix-Related Antifugal Resistance; 2.1.1 Candida albicans and other Candida spp.; 2.1.2 Aspergillus fumigatus; 3 Efflux-Pumps Activity in Fungal Biofilm and Expression of Drugs Targets; 4 Other Mechanisms Promoting Biofilm Resistance; 5 Unconventional Compounds to Implement Fungal Biofilm Treatment; 6 Drug Tolerance; 7 Conclusions; References; Fungi, Water Supply and Biofilms; 1 Introduction; 2 Biofilms in Water; 3 Methods Dedicated to Fungi Isolation from Water; 4 Fungi Isolated from Water; 5 The Fungi Isolated from Water Supply in Health Facilities
000759997 5058_ $$a6 Transmission of Fungi Responsible for Water-related Infections in Health Facilities7 Specific Case of Dental Unit Waterlines; 8 Prophylactic and Curative Actions Developed in Hospitals; 9 Conclusion; References; Diagnostic of Fungal Infections Related to Biofilms; 1 Introduction; 2 Diagnostics for Candida Infections; 2.1 Culture Based Diagnostics; 2.2 Nonculture Based Diagnostics; 3 Diagnostics for Aspergillus Infections; 3.1 Culture Based Diagnostics; 3.2 Nonculture Based Diagnostics; 4 Biofilm Production in Fungal Isolates; 5 Antifungal Susceptibility Testing Assays
000759997 5058_ $$a5.1 Planktonically-Growing Isolate Testing5.2 Sessile/Biofilm-Growing Isolate Testing; 6 Concluding Remarks/Future Perspectives; References; Disinfectants to Fight Oral Candida Biofilms; 1 Introduction; 2 Oral Candida Species ́Biofilms; 3 Oral Disinfectants; 3.1 Chlorhexidine; 3.2 Benzalkonium Chloride; 3.3 Nystatin; 3.4 Silver Nanoparticles; 3.5 Other Alternative Disinfectants; 4 Conclusions; References; Updates on Therapeutic Strategies Against Candida (and Aspergillus) Biofilm Related Infections; 1 Introduction; 2 Biology and Resistance of Biofilms
000759997 506__ $$aAccess limited to authorized users.
000759997 588__ $$aOnline resource; title from PDF title page (SpringerLink, viewed August 19, 2016).
000759997 650_0 $$aBiofilms.
000759997 650_0 $$aFungi$$xBiotechnology.
000759997 7001_ $$aImbert, Christine,$$eeditor.
000759997 830_0 $$aAdvances in experimental medicine and biology.$$pAdvances in microbiology, infectious diseases and public health ;$$vvolume 931.
000759997 852__ $$bebk
000759997 85640 $$3SpringerLink$$uhttps://univsouthin.idm.oclc.org/login?url=http://link.springer.com/10.1007/978-3-319-42360-9$$zOnline Access$$91397441.1
000759997 909CO $$ooai:library.usi.edu:759997$$pGLOBAL_SET
000759997 980__ $$aEBOOK
000759997 980__ $$aBIB
000759997 982__ $$aEbook
000759997 983__ $$aOnline
000759997 994__ $$a92$$bISE